Quotient Sciences is a UK-headquartered pharmaceutical CRDMO (contract research, development, and manufacturing organization) specializing in small molecule and synthetic peptide drug product development and manufacturing. They offer integrated formulation development, clinical manufacturing, and commercial production, with their proprietary Translational Pharmaceutics approach integrating clinical activities with real-time cGMP manufacturing. They have facilities in the US and UK, with capabilities including HPAPI manufacturing, sterile fill/finish, and oral solid dose.
Translational Pharmaceutics (integrated development/clinical approach), small molecule drug product development, HPAPI handling, sterile fill/finish, pediatric formulation development, first-in-human clinical studies
2 sites worldwide
No reviews available yet.
No documents available.